Minimal Rectal Toxicity in the Setting of Comorbid Crohn’s Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer

@inproceedings{Singh2017MinimalRT,
  title={Minimal Rectal Toxicity in the Setting of Comorbid Crohn’s Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer},
  author={Raj Singh and Philip S Jackson and Mollie Blake and James Cutlip and Sanjeev Sharma},
  booktitle={Cureus},
  year={2017}
}
We present one of the first cases of a prostate cancer (PCa) patient with inflammatory bowel disease (IBD) treated with intensity-modulated radiotherapy (IMRT) and a hydrogel rectal spacer. A 73-year-old male with a past medical history significant for Crohn's disease (CD) and the recent diagnosis of T1cN0M0 high-risk PCa was referred for definitive radiotherapy. Given the patient's history of CD and the possible increased risk of gastrointestinal (GI) toxicity and disease exacerbation, prior… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 10 REFERENCES

Long term clinical toxicity of radiation therapy in prostate cancer patients with Inflammatory Bowel Disease.

  • Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
  • 2017
VIEW 2 EXCERPTS

Hydrogel injection reduces rectal toxicity after radiotherapy for localized prostate cancer

Michael Pinkawa, Vanessa Berneking, +3 authors Michael J Eble
  • Strahlentherapie und Onkologie
  • 2016

Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.

Michael Pinkawa, Nuria Corral, +6 authors Michael J Eble
  • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2011
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…